About Venclose
Venclose is a company based in San Jose (United States) founded in 2014 by Brady Esch was acquired by Becton Dickinson in December 2021.. Venclose has raised $27.1 million across 2 funding rounds from investors including BD and Ally Bridge Group. Venclose offers products and services including Venclose RF Ablation System, Venclose RF Ablation Catheter, and Venclose Maven Perforator Catheter. Venclose operates in a competitive market with competitors including Monteris, Neo, TechsoMed, Symmetry Surgical and Misonix, among others.
- Headquarter San Jose, United States
- Founders Brady Esch
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Becton, Dickinson And Company
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$27.1 M (USD)
in 2 rounds
-
Latest Funding Round
$27.1 M (USD), Series C
Nov 27, 2019
-
Investors
BD
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Becton Dickinson
(Dec 02, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Venclose
Venclose offers a comprehensive portfolio of products and services, including Venclose RF Ablation System, Venclose RF Ablation Catheter, and Venclose Maven Perforator Catheter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for endovascular coagulation of blood vessels in venous reflux.
Device for treating superficial vein reflux with radiofrequency.
Catheter for managing perforator and tributary vein reflux.
Unlock access to complete
Unlock access to complete
Funding Insights of Venclose
Venclose has successfully raised a total of $27.1M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $27.1 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $27.1M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2019 | Amount | Series C - Venclose | Valuation | Ally Bridge Group |
|
| Jul, 2018 | Amount | Series B - Venclose | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Venclose
Venclose has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BD and Ally Bridge Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
BD is recognized for providing innovative medical technology solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Venclose
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Venclose
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Venclose Comparisons
Competitors of Venclose
Venclose operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Monteris, Neo, TechsoMed, Symmetry Surgical and Misonix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MRI-guided laser ablation tools for neurosurgery are developed.
|
|
| domain | founded_year | HQ Location |
Blockchain infrastructure is utilized for developing decentralized applications.
|
|
| domain | founded_year | HQ Location |
Ultrasound-based monitoring systems for thermal ablation procedures are developed.
|
|
| domain | founded_year | HQ Location |
Surgical instruments, sterilization solutions and electrosurgical products
|
|
| domain | founded_year | HQ Location |
Ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery
|
|
| domain | founded_year | HQ Location |
Surgical products for soft tissue cutting
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Venclose
Frequently Asked Questions about Venclose
When was Venclose founded?
Venclose was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is Venclose located?
Venclose is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Who is the current CEO of Venclose?
Brady Esch is the current CEO of Venclose. They have also founded this company.
Is Venclose a funded company?
Venclose is a funded company, having raised a total of $27.1M across 2 funding rounds to date.
What does Venclose do?
Venclose has developed a Radiofrequency (RF) ablation system for the treatment of venous reflux disease. The Venclose device consists fo two heating lengths and a catheter. The features are the instrument has markings, curved tip, minimizes invasiveness, shows real-time procedure data etc.
Who are the top competitors of Venclose?
What products or services does Venclose offer?
Venclose offers Venclose RF Ablation System, Venclose RF Ablation Catheter, and Venclose Maven Perforator Catheter.
Who are Venclose's investors?
Venclose has 2 investors. Key investors include BD, and Ally Bridge Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.